The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
More than one reason to rethink the use of peptides in vaccine design
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sallusto, F., Cella, M., Danieli, C., & Lanzavecchia, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.389 · Cited by 2,500
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
Schubert, U., Antón, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W., & Bennink, J. R. (2000) · Nature · doi:10.1038/35008096 · Cited by 1,536
IMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES
Yewdell, J. W., & Bennink, J. R. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.51 · Cited by 944
Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5586 · Cited by 830
A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides
Suto, R., & Srivastava, P. K. (1995) · Science · doi:10.1126/science.7545313 · Cited by 823
CAPTURE AND PROCESSING OF EXOGENOUS ANTIGENS FOR PRESENTATION ON MHC MOLECULES
Watts, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.821 · Cited by 763
Immunotherapy of Tumors with Autologous Tumor-Derived Heat Shock Protein Preparations
Tamura, Y., Peng, P., Liu, K., Daou, M., & Srivastava, P. K. (1997) · Science · doi:10.1126/science.278.5335.117 · Cited by 680
Anderson, R. P., Degano, P., Godkin, A. J., Jewell, D. P., & Hill, A. V. S. (2000) · Nature Medicine · doi:10.1038/73200 · Cited by 578
Moutaftsi, M., Peters, B., Pasquetto, V., Tscharke, D. C., Sidney, J., Bui, H.-H., Grey, H., & Sette, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1215 · Cited by 557
Blachere, N. E., Li, Z., Chandawarkar, R. Y., Suto, R., Jaikaria, N. S., Basu, S., Udono, H., & Srivastava, P. K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1315 · Cited by 556
Aguilar, J. C., & Rodríguez, E. G. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.111 · Cited by 494
Cross‐presentation: underlying mechanisms and role in immune surveillance
Rock, K. L., & Shen, L. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00301.x · Cited by 451
Yewdell, J. W., Antón, L. C., & Bennink, J. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1823 · Cited by 450
Skipper, J. C., Hendrickson, R. C., Gulden, P. H., Brichard, V, Van Pel, A., Chen, Y., Shabanowitz, J., Wolfel, T., Slingluff, C. L., Boon, T., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.527 · Cited by 405
Castellino, F., Boucher, P. E., Eichelberg, K., Mayhew, M., Rothman, J. E., Houghton, A. N., & Germain, R. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1957 · Cited by 404
Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle
Guo, H.-C., Jardetzky, T. S., Garrettt, T. P. J., Lane, W. S., Strominger, J. L., & Wiley, D. C. (1992) · Nature · doi:10.1038/360364a0 · Cited by 404
Bäcklund, J., Carlsen, S., Höger, T., Holm, B., Fugger, L., Kihlberg, J., Burkhardt, H., & Holmdahl, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132254199 · Cited by 394
Proteasome and peptidase function in MHC-class-I-mediated antigen presentation
Kloetzel, P.-M., & Ossendorp, F. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.004 · Cited by 393
Ackerman, A. L., Kyritsis, C., Tampé, R., & Cresswell, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735556100 · Cited by 383
Chemistry of peptides associated with MHC class I and class II molecules
Rammensee, H.-G. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80033-6 · Cited by 365
Optimization of the MHC Class I Peptide Cargo Is Dependent on Tapasin
Williams, A. P., Peh, C. A., Purcell, A. W., McCluskey, J., & Elliott, T. (2002) · Immunity · doi:10.1016/s1074-7613(02)00304-7 · Cited by 353
Self-citationSingh-Jasuja, H., Toes, R. E. M., Spee, P., Münz, C., Hilf, N., Schoenberger, S. P., Ricciardi-Castagnoli, P., Neefjes, J., Rammensee, H.-G., Arnold-Schild, D., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1965 · Cited by 348
Immune recognition of a human renal cancer antigen through post-translational protein splicing
Hanada, K.-I., Yewdell, J. W., & Yang, J. C. (2004) · Nature · doi:10.1038/nature02240 · Cited by 336
Dranoff, G. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18813.x · Cited by 334
An Antigenic Peptide Produced by Peptide Splicing in the Proteasome
Vigneron, N., Stroobant, V., Chapiro, J., Ooms, A., Degiovanni, G., Morel, S., van der Bruggen, P., Boon, T., & Van den Eynde, B. J. (2004) · Science · doi:10.1126/science.1095522 · Cited by 330
Epitope-based vaccines: an update on epitope identification, vaccine design and delivery
Sette, A., & Fikes, J. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00083-9 · Cited by 322
Slansky, J. E., Rattis, F. M., Boyd, L. F., Fahmy, T., Jaffee, E. M., Schneck, J. P., Margulies, D. H., & Pardoll, D. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00052-2 · Cited by 309
Roles of heat-shock proteins in antigen presentation and cross-presentation
Li, Z., Menoret, A., & Srivastava, P. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00297-7 · Cited by 297
Brusic, V, Rudy, G., Honeyman, G., Hammer, J., & Harrison, L. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.2.121 · Cited by 292
A Community Resource Benchmarking Predictions of Peptide Binding to MHC-I Molecules
Peters, B., Bui, H.-H., Frankild, S., Nielsen, M., Lundegaard, C., Kostem, E., Basch, D., Lamberth, K., Harndahl, M., Fleri, W., et al. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020065 · Cited by 288
Meadows, L., Wang, W., den Haan, J. M. M., Blokland, E., Reinhardus, C., Drijfhout, J. W., Shabanowitz, J., Pierce, R., Agulnik, A. I., Bishop, C. E., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80330-1 · Cited by 284
β-Amino Acids: Versatile Peptidomimetics
Steer, D., Lew, R., Perlmutter, P., Smith, A., & Aguilar, M.-I. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867024606759 · Cited by 279
Braud, V. M., Allan, D. S. J., Wilson, D., & McMichael, A. J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70014-4 · Cited by 277
Post-proteasomal antigen processing for major histocompatibility complex class I presentation
Rock, K. L., York, I. A., & Goldberg, A. L. (2004) · Nature Immunology · doi:10.1038/ni1089 · Cited by 273
Tumor-Derived Heat Shock Protein 70 Peptide Complexes Are Cross-Presented by Human Dendritic Cells
Noessner, E., Gastpar, R., Milani, V., Brandl, A., Hutzler, P. J. S., Kuppner, M. C., Roos, M., Kremmer, E., Asea, A., Calderwood, S. K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5424 · Cited by 262
Peh, C. A., Burrows, S. R., Barnden, M., Khanna, R., Cresswell, P., Moss, D. J., & McCluskey, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80558-0 · Cited by 252
Self-citationBasu, S., & Srivastava, P. K. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.797 · Cited by 252
Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments
Reid, P. A., & Watts, C. (1990) · Nature · doi:10.1038/346655a0 · Cited by 251
Lee, P., Wang, F., Kuniyoshi, J., Rubio, V., Stuge, T., Groshen, S., Gee, C., Lau, R., Jeffery, G., Margolin, K., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3836 · Cited by 244
Kloetzel, P. M. (2004) · Nature Immunology · doi:10.1038/ni1090 · Cited by 242
Cross-presentation: a general mechanism for CTL immunity and tolerance
Carbone, F. R., Kurts, C., Bennett, S. R. M., Miller, J. F. A. P., & Heath, W. R. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01301-2 · Cited by 241
The insulin A-chain epitope recognized by human T cells is posttranslationally modified
Mannering, S. I., Harrison, L. C., Williamson, N. A., Morris, J. S., Thearle, D. J., Jensen, K. P., Kay, T. W. H., Rossjohn, J., Falk, B. A., Nepom, G. T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051251 · Cited by 231
Self-citationMacdonald, W. A., Purcell, A. W., Mifsud, N. A., Ely, L. K., Williams, D. S., Chang, L., Gorman, J. J., Clements, C. S., Kjer-Nielsen, L., Koelle, D. M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030066 · Cited by 204
Self-citationHeteroclitic Immunization Induces Tumor Immunity
Dyall, R., Bowne, W. B., Weber, L. W., LeMaoult, J., Szabo, P., Moroi, Y., Piskun, G., Lewis, J. J., Houghton, A. N., & Nikolić-Žugić, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1553 · Cited by 200
Tynan, F. E., Reid, H. H., Kjer-Nielsen, L., Miles, J. J., Wilce, M. C. J., Kostenko, L., Borg, N. A., Williamson, N. A., Beddoe, T., Purcell, A. W., et al. (2007) · Nature Immunology · doi:10.1038/ni1432 · Cited by 195
Self-citationIdentification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy
Zarling, A. L., Polefrone, J. M., Evans, A. M., Mikesh, L. M., Shabanowitz, J., Lewis, S. T., Engelhard, V. H., & Hunt, D. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604045103 · Cited by 193
Haurum, J. S., Arsequell, G., Lellouch, A. C., Wong, S. Y., Dwek, R. A., McMichael, A. J., & Elliott, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.739 · Cited by 184
Post-translational modifications of self antigens: implications for autoimmunity
Anderton, S. M. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.09.001 · Cited by 170
ISCOMTM‐based vaccines: The second decade
Sanders, M. T., Brown, L. E., Deliyannis, G., & Pearse, M. J. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01319.x · Cited by 166
Zernich, D., Purcell, A. W., Macdonald, W. A., Kjer-Nielsen, L., Ely, L. K., Laham, N., Crockford, T., Mifsud, N. A., Bharadwaj, M., Chang, L., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031680 · Cited by 160
Self-citationKersten, G. F. A. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00540-6 · Cited by 156
Peptides and Peptidomimetics in Medicine, Surgery and Biotechnology
Gentilucci, L., Tolomelli, A., & Squassabia, F. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777935041 · Cited by 155
Tynan, F. E., Borg, N. A., Miles, J. J., Beddoe, T., Elhassen, D., Silins, S. L., van Zuylen, W. J., Purcell, A. W., Kjer‐Nielsen, L., McCluskey, J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503060200 · Cited by 152
Self-citationTangri, S., Ishioka, G. Y., HUANG, X., Sidney, J., Southwood, S., Fikes, J. D., & Sette, A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.833 · Cited by 147
Quantitative and Qualitative Influences of Tapasin on the Class I Peptide Repertoire
Purcell, A. W., Gorman, J. J., García-Peydró, M., Paradela, A., Burrows, S. R., Talbo, G. H., Laham-Karam, N., Peh, C. A., Reynolds, E. C., de Castro, J. A. Ł., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1016 · Cited by 146
Self-citationFirbas, C., Jilma, B., Tauber, E., Buerger, V., Jelovcan, S., Lingnau, K., Buschle, M., Frisch, J., & Klade, C. S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.009 · Cited by 144
Saponin-adjuvanted particulate vaccines for clinical use
Skene, C. D., & SUTTON, P. R. N. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.019 · Cited by 133
Have we cut ourselves too short in mapping CTL epitopes?
Burrows, S. R., Rossjohn, J., & McCluskey, J. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.11.001 · Cited by 130
Self-citationChianese‐Bullock, K. A., Pressley, J., Garbee, C. F., Hibbitts, S., Murphy, C., Yamshchikov, G. V., Petroni, G. R., Bissonette, E. A., Neese, P. Y., Grosh, W. W., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.3080 · Cited by 126
Post-translational modifications of naturally processed MHC-binding epitopes
Engelhard, V. H., Altrich-VanLith, M. L., Ostankovitch, M., & Zarling, A. L. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.015 · Cited by 124
Singh‐Jasuja, H., Emmerich, N., & Rammensee, H. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0480-x · Cited by 124
A Novel Chemical Approach to Drug Delivery: Lipidic Amino Acid Conjugates
Tóth, I. (1994) · Journal of drug targeting · doi:10.3109/10611869408996805 · Cited by 120
Crystal Structure of an MHC Class I Presented Glycopeptide that Generates Carbohydrate-Specific CTL
Speir, J. A., Abdel‐Motal, U. M., Jondal, M., & Wilson, I. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80006-0 · Cited by 118
Speir, J. A., Stevens, J., Joly, E., Butcher, G. W., & Wilson, I. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00091-7 · Cited by 110
Toward a Definition of Self: Proteomic Evaluation of the Class I Peptide Repertoire
Hickman, H. D., Luis, A. D., Buchli, R., Few, S. R., Sathiamurthy, M., VanGundy, R. S., Giberson, C. F., & Hildebrand, W. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2944 · Cited by 109
Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix
Schafer, J. L. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00173-x · Cited by 106
Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity
Petrovsky, N. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.107 · Cited by 105
Pruksakorn, S., Currie, B. J., Brandt, E. R., Phornphutkul, C., Hunsakunachal, S., Manmontri, A., Robinson, J. H., Kehoe, M., Galbraith, A. J., & Good, M. F. (1994) · International Immunology · doi:10.1093/intimm/6.8.1235 · Cited by 105
Park, B., Lee, S., Kim, E., & Ahn, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.961 · Cited by 94
CTL Recognition of a Bulged Viral Peptide Involves Biased TCR Selection
Miles, J. J., Elhassen, D., Borg, N. A., Silins, S. L., Tynan, F. E., Burrows, J. M., Purcell, A. W., Kjer‐Nielsen, L., Rossjohn, J., Burrows, S. R., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3826 · Cited by 93
Self-citationCao, Goodin, R. R., Wood, D. D., Moscarello, M. A., & Whitaker, J. N. (1999) · Biochemistry · doi:10.1021/bi982960s · Cited by 89
Adjuvanticity of α2-Macroglobulin, an Independent Ligand for the Heat Shock Protein Receptor CD91
Binder, R. J., Karimeddini, D., & Srivastava, P. K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4968 · Cited by 86
Kuckelkorn, U., Ruppert, T., Strehl, B., Jungblut, P. R., Zimny‐Arndt, U., Lamer, S., Prinz, I., Drung, I., Kloetzel, P., Kaufmann, S. H. E., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011199 · Cited by 84
Cancer Vaccines: Preclinical Studies and Novel Strategies
Palena, C., Abrams, S. I., Schlom, J., & Hodge, J. W. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95004-0 · Cited by 82
Dakappagari, N. K., Pyles, J. A., Parihar, R., Carson, W. E., Young, D. C., & Kaumaya, P. T. P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4242 · Cited by 73
Ireland, J. M., Herzog, J., & Unanue, E. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1421 · Cited by 68
Description and prediction of peptide-MHC binding: the ‘human MHC project’
Buus, S. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80035-1 · Cited by 68
Peptide exchange in MHC molecules
Jensen, P. E., Weber, D. A., Thayer, W. R., Westerman, L. E., & Dao, C. T. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01368.x · Cited by 63
van Stipdonk, M. J. B. (1998) · International Immunology · doi:10.1093/intimm/10.7.943 · Cited by 62
Luft, T., Rizkalla, M., Tai, T. Y., Chen, Q., Macfarlan, R. I., Davis, I. D., Maraskovsky, E., & Cebon, J. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2529 · Cited by 61
Purcell, A. W., Zeng, W., Mifsud, N. A., Ely, L. K., Macdonald, W. A., & Jackson, D. C. (2003) · Journal of Peptide Science · doi:10.1002/psc.456 · Cited by 60
Self-citationWebb, A. I., Dunstone, M. A., Williamson, N. A., Price, J. D., de Kauwe, A., Chen, W., Oakley, A., Perlmutter, P., McCluskey, J., Aguilar, M.-I., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3810 · Cited by 57
Self-citationChen, W., Ede, N. J., Jackson, D. C., McCluskey, J., & Purcell, A. W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1000 · Cited by 55
Self-citationDendritic Cell-Derived Exosomes as Cell-Free Peptide-Based Vaccines
Taïeb, J., Chaput, N., & Zitvogel, L. (2005) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v25.i3.30 · Cited by 52
Falk, K., Lau, J. M., Santambrogio, L., Marin‐Esteban, V., Puentes, F., Rötzschke, O., & Strominger, J. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109098200 · Cited by 52
Guichard, G., Zerbib, A., Le Gal, F.-A., Hoebeke, J., Connan, F., Choppin, J., Briand, J.-P., & Guillet, J.-G. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000909s · Cited by 51
Val, M. D., & López, D. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00104-9 · Cited by 49
West, M. A., Antoniou, A. N., Prescott, A. R., Azuma, T., Kwiatkowski, D. J., & Watts, C. K. W. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3450::aid-immu3450>3.0.co;2-a · Cited by 46
Reinelt, S., Martí, M., Dédier, S., Reitinger, T., Folkers, G., de Castro, J. A. Ł., & Rognan, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102772200 · Cited by 46
Lipid-based Self-Adjuvanting Vaccines
Brown, L. E., & Jackson, D. C. (2005) · Current Drug Delivery · doi:10.2174/156720105774370258 · Cited by 45
Prediction of supertype-specific HLA class I binding peptides using support vector machines
Zhang, G., Božić, I., Kwoh, C. K., August, J. T., & Brusić, V. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.12.011 · Cited by 40
T Cell Recognition of the Dominant I-Ak–Restricted Hen Egg Lysozyme Epitope
McAdam, S. N., Fleckenstein, B. T., Rasmussen, I. B., Schmid, D. G., Sandlie, I., Bogen, B., Viner, N. J., & Sollid, L. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1239 · Cited by 38
Marschütz, M. K., Zauner, W., Mattner, F., Otava, A., Buschle, M., & Bernkop-Schnürch, A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00148-1 · Cited by 24
The peptide-loading complex and ligand selection during the assembly of HLA class I molecules
Purcell, A. W. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00075-4 · Cited by 19
Self-citationSesma, L., Galocha, B., Vázquez, M., Purcell, A. W., Marcilla, M., McCluskey, J., & de Castro, J. A. Ł. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7833 · Cited by 16
Self-citationDu, A. P. C., Limal, D., Semetey, V., Dali, H., Jolivet, M., Des̀granges, C., Cung, M. T., Briand, J., Averlant‐Petit, M., & Muller, S. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00701-5 · Cited by 16
Use of proteomics to define targets of T-cell immunity
Williamson, N. A., & Purcell, A. W. (2005) · Expert Review of Proteomics · doi:10.1586/14789450.2.3.367 · Cited by 11
Self-citationOptimisation of peptide-based cytotoxic T-cell determinants using
Webb, A. I., Aguilar, M., & Purcell, A. W. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442589 · Cited by 9
Self-citation
Cited by
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 771
Peptide Vaccine: Progress and Challenges
Li, W., Joshi, M., Singhania, S., Ramsey, K., & Murthy, A. (2014) · Vaccines · doi:10.3390/vaccines2030515 · Cited by 679
Peptide-based synthetic vaccines
Skwarczynski, M., & Toth, I. (2016) · Chemical Science · doi:10.1039/c5sc03892h · Cited by 596
A self-assembling peptide acting as an immune adjuvant
Rudra, J. S., Tian, Y. F., Jung, J. P., & Collier, J. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912124107 · Cited by 523
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Metadata
- Authors
- Purcell, A. W., McCluskey, J., & Rossjohn, J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-05
- Volume
- 6
- Issue
- 5
- Pages
- 404-414
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2034694458
- Cited by
- 860
- References
- 99
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.